Zhang Qiang, Chen Hongxing, Zhu Chao, Chen Fangzhou, Sun Suohui, Liang Nan, Zheng Wei
Emergency Department, Tai'an Traditional Chinese Medicine Hospital, Tai'an, Shandong 271000, P.R. China.
Department of ICU, Affiliated Hospital of Taishan Medical University, Tai'an, Shandong 271000, P.R. China.
Exp Ther Med. 2019 Jun;17(6):4605-4609. doi: 10.3892/etm.2019.7503. Epub 2019 Apr 18.
This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial trauma operation in Tai'an Traditional Chinese Medicine Hospital and Affiliated Hospital of Taishan Medical University from May 2004 to June 2017. The patients were divided into the control group (43 patients) and the experimental group (43 patients) according to the treatment. Patients in the control group were intravenously infused with vancomycin hydrochloride (1.0 g, Q12H) and meropenem (2.0 g, Q8H). After lumbar cistern drainage was performed for the release of cerebrospinal fluid (CSF), patients in the experimental group were slowly given vancomycin 20 mg. After the tube was flushed with 2 ml of 0.9% sodium chloride injection, the patients were slowly given meropenem 20 mg, bid. The clinical efficacy, cure time and treatment cost of patients in the two groups were observed. The adverse reactions and sequelae after 6 months of treatment were recorded. The response rate (RR) of patients in the experimental group was significantly higher than that in the control group (P<0.05). The cure time of patients in the experimental group was significantly lower than that in the control group (P<0.05). The treatment cost of patients in the experimental group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions of patients, incidence of sequelae of patients in the experimental group was significantly lower than that in the control group (P<0.05). Intrathecal meropenem and vancomycin is more effective than intravenous administration in the treatment of intracranial infection after craniotomy. It can significantly shorten the treatment time and reduce the treatment cost, with better safety.
本研究探讨了鞘内注射美罗培南和万古霉素治疗重度创伤性脑损伤(STBI)患者术后颅内感染的疗效及安全性。对2004年5月至2017年6月在泰安市中医医院及泰山医学院附属医院行颅脑外伤手术后发生颅内感染的86例患者进行回顾性分析。根据治疗方法将患者分为对照组(43例)和试验组(43例)。对照组患者静脉滴注盐酸万古霉素(1.0 g,每12小时1次)和美罗培南(2.0 g,每8小时1次)。试验组患者在进行腰大池引流释放脑脊液(CSF)后,缓慢鞘内注射万古霉素20 mg。用2 ml 0.9%氯化钠注射液冲洗导管后,缓慢鞘内注射美罗培南20 mg,每日2次。观察两组患者的临床疗效、治愈时间及治疗费用。记录治疗6个月后的不良反应及后遗症。试验组患者的有效率(RR)显著高于对照组(P<0.05)。试验组患者的治愈时间显著低于对照组(P<0.05)。试验组患者的治疗费用显著低于对照组(P<0.05)。试验组患者的不良反应发生率、后遗症发生率显著低于对照组(P<0.05)。鞘内注射美罗培南和万古霉素治疗开颅术后颅内感染比静脉给药更有效。它能显著缩短治疗时间,降低治疗费用,安全性更好。